# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Jim Thorpe (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML011-SYN
- Date: 2026-06-08
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nolan Fairbanks, MD
- Calendar frame: modern shifted

## What we are working on

- A sore on his lower lip has not healed for three months, and he wants to know whether it is cancer **S**
- He gets tight in the chest walking uphill and wants to stay active enough to keep coaching **S**
- He wants his care to respect who he is and to be told plainly about costs and choices **S**

## Your goals

- Lip cancer removed with clear margins and no recurrence on surveillance through four months. Target: 2026-10-26. Recorded outcome: Excised with clear margins; no recurrence or neck nodes at four months. **S**
- LDL cholesterol below 55 mg/dL on secondary prevention. Target: 2026-09-21. Recorded outcome: LDL 51 mg/dL on atorvastatin 80 mg and ezetimibe 10 mg. **S**
- Blood pressure below 130/80 mmHg. Target: 2026-09-21. Recorded outcome: 124/76 on metoprolol. **S**
- Complete cardiac rehabilitation and walk uphill without angina. Target: 2026-10-26. Recorded outcome: 30 of 36 sessions done; no angina and no nitroglycerin use for two months. **S**
- Stay tobacco-free and protect his lips and skin from the sun. Target: 2026-10-26. Recorded outcome: Tobacco-free; lip balm with sunscreen and a hat used daily. **S**

## What we agreed to do

- Incisional biopsy of the lip lesion today, with pathology; sun protection for the lips and skin (lip balm with SPF 30 or higher, a broad-brimmed hat); dental review. Guideline: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (cancer of the lip and oral cavity) (2026); Skin Cancer Prevention: Behavioral Counseling (2018) **S**
- Otolaryngology (head and neck surgery) consultation for a suspected lip cancer: staging, treatment, management of the neck, and surveillance. Guideline: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (cancer of the lip and oral cavity) (2026) **S**
- Secondary prevention for chronic coronary disease: aspirin 81 mg daily, atorvastatin 80 mg with a lipid panel 4 to 12 weeks after starting and a goal LDL below 55 mg/dL, metoprolol succinate for angina, sublingual nitroglycerin with written instructions, blood pressure below 130/80, an echocardiogram to measure heart function before surgery, and staying tobacco-free. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease monograph (2026) **S**
- Cardiac rehabilitation once the lip wound has healed: up to 36 supervised exercise and education sessions for stable angina, with nutrition, activity, and risk-factor coaching. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease monograph (2026) **S**
- Care organized around his choices: information about Sac and Fox Nation health services and Indian Health Service, tribal, and urban Indian health programs, help to use them if he wishes, and room for any traditional or spiritual practices he chooses; costs and options explained plainly. Guideline: Purchased/Referred Care (2026) **S**
- V-excision of the lip cancer under local anesthesia with 5 to 10 mm clinical margins and frozen-section margin control, primary closure; contrast CT of the neck before surgery; no elective neck dissection if the final depth of invasion is small; aspirin and metoprolol continued through surgery. Guideline: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (cancer of the lip and oral cavity) (2026); 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery (2024) **S**
- Surveillance after lip cancer: history and examination of the lips, mouth and neck every 1 to 3 months in the first year, every 2 to 6 months in the second, every 4 to 8 months in years 3 to 5, then yearly; whole-skin examination; dental care; tobacco-free; imaging only for symptoms or findings. Guideline: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (cancer of the lip and oral cavity) (2026) **S**
- Ezetimibe 10 mg daily added to atorvastatin because LDL was 68 mg/dL, above the goal of 55 mg/dL, with a lipid panel 4 to 12 weeks later. Guideline: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease monograph (2026) **S**

## Follow-up

- 2026-06-08: New patient with a non-healing sore on the lower lip and chest tightness on exertion: lip biopsy, coronary disease assessment, secondary prevention, and care preferences **S**
- 2026-06-15: Lip biopsy result and otolaryngology (head and neck surgery) consultation; echocardiogram and readiness for surgery **S**
- 2026-07-13: Two weeks after excision of the lip cancer: pathology, wound check, surveillance plan, lipid recheck, and cardiac rehabilitation **S**
- 2026-09-21: Coronary disease review in cardiac rehabilitation, lipid recheck after ezetimibe, and lip surveillance **S**
- 2026-10-05: Periodic adult preventive visit **S**
- 2026-10-26: Four months after surgery: lip and neck surveillance, coronary disease review, and screening results **S**

This teaching document does not replace care from a qualified clinician.
